Immunogenicity up to age 5 years following a single-dose or two-dose infant primary series of 10-valent or 13-valent pneumococcal conjugate vaccine each followed by a booster dose in South Africa: extended follow-up of a single-centre, open-label, non-inferiority, randomised controlled trial.
- DOI
- 10.1016/s2352-4642(26)00164-1
- Published
- 2026 Sep 8
- Container
- The Lancet. Child & adolescent health
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2352-4642-26-00164-1,
title = {Immunogenicity up to age 5 years following a single-dose or two-dose infant primary series of 10-valent or 13-valent pneumococcal conjugate vaccine each followed by a booster dose in South Africa: extended follow-up of a single-centre, open-label, non-inferiority, randomised controlled trial.},
author = {Kapelus DJ and Olwagen CP and Izu A and Ranchod H and Mukendi CK and Mutsaerts EAML and Koen A and Jose L and Kwatra G and Faustini SE and Richter AG and Madhi SA},
year = {2026},
journal = {The Lancet. Child \& adolescent health},
doi = {10.1016/s2352-4642(26)00164-1},
url = {https://doi.org/10.1016/s2352-4642(26)00164-1}
}RIS
TY - JOUR TI - Immunogenicity up to age 5 years following a single-dose or two-dose infant primary series of 10-valent or 13-valent pneumococcal conjugate vaccine each followed by a booster dose in South Africa: extended follow-up of a single-centre, open-label, non-inferiority, randomised controlled trial. AU - Kapelus DJ AU - Olwagen CP AU - Izu A AU - Ranchod H AU - Mukendi CK AU - Mutsaerts EAML AU - Koen A AU - Jose L AU - Kwatra G AU - Faustini SE AU - Richter AG AU - Madhi SA PY - 2026 JO - The Lancet. Child & adolescent health DO - 10.1016/s2352-4642(26)00164-1 UR - https://doi.org/10.1016/s2352-4642(26)00164-1 ER -
APA
DJ, K., CP, O., A, I., H, R., CK, M., EAML, M., A, K., L, J., G, K., SE, F., AG, R., & SA, M. (2026). Immunogenicity up to age 5 years following a single-dose or two-dose infant primary series of 10-valent or 13-valent pneumococcal conjugate vaccine each followed by a booster dose in South Africa: extended follow-up of a single-centre, open-label, non-inferiority, randomised controlled trial.. The Lancet. Child & adolescent health. https://doi.org/10.1016/s2352-4642(26)00164-1
Source records
- pubmed · retrieved 2026-09-26T04:04:36.276Z